Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

A Review About the Drug Delivery from Microsponges

Abstract

Microparticulate drug delivery systems have shown a great interest in the pharmaceutical area. They allow the increase of drug therapeutic efficacy and the reduction of side effects. In this context, microsponges represent a new model of porous polymer microspheres, which allow the entrapment of a wide range of active agents. During the development, it is necessary the characterization of the system and among of the most important tests are the release and permeation profile analysis. They can demonstrate the behavior of drug in a specific site with a particular application condition and are related to therapeutic efficacy. Therefore, this review provides an overview of drug delivery profile from microsponges. Methods for determination of in vitro release and ex vivo permeation studies are detailed. Examples of drug delivery from microsponges administered in different sites are also discussed with aim to provide an understanding of the use of this strategy to modify the drug delivery.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. 1.

    Restani RB, Correia VG, Bonifácio VDB, Aguiar-Ricardo A. Development of functional mesoporous microparticles for controlled drug delivery. J Supercrit Fluids. 2010;55(1):333–9.

  2. 2.

    Orlu M, Cevher E, Araman A. Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges. Int J Pharm. 2006;318:103–17.

  3. 3.

    Li S, Li G, Liu L, Jiang X, Zhang B, Liu Z, et al. Evaluation of paeonol skin-target delivery from its microsponge formulation: in vitro skin permeation and in vivo microdialysis. PLoS One. 2013;8(11):1–8.

  4. 4.

    Aloorkar NH, Kulkarni a S, Ingale DJ, Patil R a. Microsponges as innovative drug delivery systems. Int J Pharm Sci Nanotechnol 2012;5(1):1597–1606.

  5. 5.

    Jain N, Sharma PK, Banik A. Recent advances on microsponge delivery system. Int J Pharm Sci Res. 2011;8(2):13–23.

  6. 6.

    Crcarevska MS, Dimitrovska A, Sibinovska N, Mladenovska K, Raicki RS, Dodov MG. Implementation of quality by design principles in the development of microsponges as drug delivery carriers: identification and optimization of critical factors using multivariate statistical analyses and design of experiments studies. Int J Pharm. 2015;489(1–2):58–72.

  7. 7.

    Pandey P, Jain V, Mahajan S. A review: microsponge drug delivery system. Int J Biopharm. 2013;4(3):225–30.

  8. 8.

    Charde MS, Ghanawat PB, Welankiwar AS, Kumar J, Chakole RD. Microsponge A Novel new drug delivery system: a review. Int J Adv Pharm. 2013;2(6):63–70.

  9. 9.

    Lalitha SK, Shankar M, Likhitha D, Dastagiri J, Babu MN. A current view on microsponge drug delivery system. Eur J Mol biollogy Biochemist 2016;3(2):88–95.

  10. 10.

    Ravi R, Senthilkumar SK, Parthiban S. Microsponges drug delivery system: a review. Int J Pharm Rev Res. 2012;2(2):11–6.

  11. 11.

    Roy A. Microsponge as a novel drug carrier system: a review. World J Pharm Res. 2015;4(12):680–701.

  12. 12.

    Srivastava R, Pathak K. Microsponges: a futuristic approach for oral drug delivery. Expert Opin Drug Deliv. 2012;9(7):863–78.

  13. 13.

    Swati KV, Shalini R, Kanchan M, Ashwini C, Eknath P. Microsponge: comprehensive review of application. Int J Pharm Biol Sci. 2013;3(1).

  14. 14.

    Kumari A, Jain A, Hurkat P, Verma A, Jain SK. Microsponges: a pioneering tool for biomedical applications. Ther drug Carr Syst. 2016;33(1):77–105.

  15. 15.

    Patil RS, Kemkar VU, Patil SS. Microsponge drug delivery system: a novel dosage form. Am J PharmTech Res. 2012;2:227–51.

  16. 16.

    Jadhav N, Patel V, Mungekar S, Bhamare G, Karpe M. Microsponge delivery system: an updated review, current status and future prospects. J Sci Innov Res. 2013;2(6):1097–110.

  17. 17.

    Patil TS, Nalawade NA, Kakade VK, Kale SN. Nanosponges : A Novel Targeted Drug delivery for cancer treatment. Int J Adv Res Dev 2017;2(4):55–62.

  18. 18.

    Nokhodchi A, Jelvehgari M, Siahi MR, Mozafari MR. Factors affecting the morphology of benzoyl peroxide microsponges. Micron. 2007;38:834–40.

  19. 19.

    Angamuthu M, Nanjappa SH, Raman V, Jo S, Cegu P, Murthy SN. Controlled-release injectable containing terbinafine/PLGA microspheres for onychomycosis treatment. J Pharm Sci. 2014;103(4):1178–83.

  20. 20.

    Saxena S, Nacht S. Polymeric porous delivery systems: polytrap and microsponge. In: Delivery system handbook for personal care and cosmetic products: technology, applications, and formulations. William Andrew Inc.; 2005. p. 333–352.

  21. 21.

    Kumar PM, Ghosh A. Development and evaluation of silver sulfadiazine loaded microsponge based gel for partial thickness (second degree) burn wounds. Eur J Pharm Sci. 2017;96:243–54.

  22. 22.

    Çomoglu T, Gönül N, Baykara T. Preparation and in vitro evaluation of modified release ketoprofen microsponges. Farm. 2003;58:101–6.

  23. 23.

    Shah DK, Agrawal A. Formulation and evaluation of polymeric microsponges of ketoconazole for topical delivery. World J Pharm Pharm Sci. 2016;5(10):939–962.

  24. 24.

    Nocent M, Bertocchi L, Espitalier F, Baron M, Couarraze G. Definition of a solvent system for spherical crystallization of salbutamol sulfate by quasi-emulsion solvent diffusion (QESD) method. J Pharm Sci. 2001;90(10):1620–7.

  25. 25.

    Abdelmalak NS, El-Menshawe SF. A new topical fluconazole microsponge loaded hydrogel: preparation and characterization. Int J Pharm Pharm Sci 2012;4(1):460–468.

  26. 26.

    Pande VV, Kadnor NA, Kadam RN, Upadhye SA. Fabrication and characterization of sertaconazole nitrate microsponge as a topical drug delivery system. Indian J Pharm Sci. 2015;77(6):675–80.

  27. 27.

    Bothiraja C, Ghopal AD, Shaikh K, Pawar AP. Investigation of ethyl cellulose microsponge gel for topical delivery of eberconazole nitrate for fungal therapy. Ther Deliv 2014;5:781–794.

  28. 28.

    Mehta M, Panchal A, Shah VH, Upadhyay U. Formulation and in-vitro evaluation of controlled release microsponge gel for topical delivery of clotrimazole. Int J. Adv Pharm. 2012;2(2):93–101.

  29. 29.

    Amrutiya N, Bajaj A, Madan M. Development of microsponges for topical delivery of mupirocin. AAPS PharmSciTech. 2009;10(2):402–9.

  30. 30.

    Kumar PM, Ghosh A. Development and evaluation of metronidazole loaded microsponge based gel for superficial surgical wound infections. J Drug Deliv Sci Technol. 2015;30:15–29.

  31. 31.

    Srivastava R, Kumar D, Pathak K. Colonic luminal surface retention of meloxicam microsponges delivered by erosion based colon-targeted matrix tablet. Int J Pharm. 2012;427(2):153–62.

  32. 32.

    Kadam V V., Patel VI, Karpe MS, Kadam VJ. Design, development and evaluation of celecoxib-loaded microsponge-based topical gel formulation. Appl Clin Res Clin trials Regul Aff 2016;4(3):44–55.

  33. 33.

    Çomoglu T, Gönül N, Baykara T. The effects of pressure and direct compression on tabletting of microsponges. Int J Pharm. 2002;242(1–2):191–5.

  34. 34.

    Osmani RAM, Aloorkar NH, Ingale DJ, Kulkarni PK, Hani U, Bhosale RR, et al. Microsponges based novel drug delivery system for augmented arthritis therapy. Saudi Pharm J. 2015;23(5):562–72.

  35. 35.

    Singh S, Pathak K. Assessing the bioadhesivity of Acconon MC 8-2 EP/NF for gastroretention of floating microsponges of loratadine and achieving controlled drug delivery. Pharm Biomed Res. 2016;2(2):58–74.

  36. 36.

    Charagonda S, Puligilla RD, Ananthula MB, Bakshi V. Formulation and evaluation of famotidine floating microsponges. Int Res J Pharm. 2016;7(4):62–7.

  37. 37.

    Kumar JR, Muralidharan S, Ramasamy S. Microsponges enriched gel (MEGs): a novel strategy for opthalmic drug delivery system containing ketotifen. J Pharm Sci Res. 2013;5(4):97–102.

  38. 38.

    Raghuvanshi S, Pathak K. Bioadhesive floating microsponges of cinnarizine as novel gastroretentive delivery: Capmul GMO bioadhesive coating versus acconon MC 8 - 2 EP / NF with intrinsic bioadhesive property. Int J Pharm Investig. 2016;6(4):181–93.

  39. 39.

    Bhandare CR, Katti SA. Formulation of microsponges of risperidone HCl. Int J Res Pharm Chem. 2016;6(3):518–27.

  40. 40.

    Muralidhar P, Bhargav E, Srinath B. Fomulation and optimization of bupropion HCl microsponges by 23 factorial design. Int J Pharm Sci Res 2017;8(3):1134–1144.

  41. 41.

    Gupta A, Tiwari G, Tiwari R, Srivastava R. Factorial designed 5-fluorouracil-loaded microsponges and calcium pectinate beads plugged in hydroxypropyl methylcellulose capsules for colorectal cancer. Int J Pharm Investig. 2015;5(4):234–46.

  42. 42.

    Steyn D, Plessis L, Kotzé A. Nasal delivery of recombinant human growth hormone: in vivo evaluation with Pheroid technology and N-trimethyl chitosan chloride. J Pharm Pharm Sci. 2010;13(2):263–73.

  43. 43.

    Osmani RAM, Aloorkar NH, Thaware BU, Kulkarni PK, Moin A, Hani U, et al. Microsponge based drug delivery system for augmented gastroparesis therapy: Formulation development and evaluation.. Asian J Pharm Sci. 2015;10(5):442–51.

  44. 44.

    Jelvehgari M, Siahi-shadbad MR, Azarmi S, Martin GP, Nokhodchi A. The microsponge delivery system of benzoyl peroxide: preparation, characterization and release studies. Int J Pharm. 2006;308:124–32.

  45. 45.

    Annu P, Kumar AY. Design and evaluation of celecoxib microsponge. Int J Pharma Sci Res. 2016;7(10):396–405.

  46. 46.

    Jain V, Jain D, Singh R. Factors effecting the morphology of Eudragit S-100 based microsponges bearing dicyclomine for colonic delivery. J Pharm Sci. 2010;100(4):1545–52.

  47. 47.

    Arya P, Pathak K. Assessing the viability of microsponges as gastro retentive drug delivery system of curcumin: optimization and pharmacokinetics. Int J Pharm. 2014;460:1–2):1–12.

  48. 48.

    Chien YW. Novel drug delivery systems. 2. New York: Marcel Dekker; 2001. 300–375 p.

  49. 49.

    Ansel HC, Popovich NG, Allen Jr LV. Farmacotécnica: formas farmacêuticas e sistema de liberação de fármacos. 6 ed. Premier; 2000. 568 p.

  50. 50.

    Abd E, Yousef SA, Pastore MN, Telaprolu K, Mohammed YH, Namjoshi S, et al. Skin models for the testing of transdermal drugs. Clin Pharmacol Adv Appl. 2016;8:163–76.

  51. 51.

    Florence AT, Attwood D. Physicochemical principles of pharmacy. 6th ed. London and Chicago: Pharmaceutical Press; 2016. 648 p.

  52. 52.

    Castro P, Madureira R, Sarmento B, Pintado M. Tissue-based in vitro and ex vivo models for buccal permeability studies. In: Concepts and models for drug permeability studies; 2016. p. 189–202.

  53. 53.

    Cabrera-Pérez MÁ, Sanz MB, Sanjuan VM, González-Álvarez M, Álvarez IG. Importance and applications of cell- and tissue-based in vitro models for drug permeability screening in early stages of drug development. In: Concepts and models for drug permeability Studies. 2016. p. 3–29.

  54. 54.

    Machado A, Neves J das. Tissue-based in vitro and ex vivo models for dermal permeability studies. Concepts and Models for Drug Permeability Studies. 2016. 325–342 p.

  55. 55.

    Lakshmi CS, Badarinath AV. An updated review of dissolution apparatus for conventional and novel dosage forms. Int J Pharma Res Rev. 2013;2(27):42–53.

  56. 56.

    Crist GB. Dissolution equipment. In: Palmieri A, editor. Dissolution theory, methodology, and testing. Dissolution technologies, Inc.; 2007. p. 33–66.

  57. 57.

    Gohel MC, Mehta PR, Dave RK, Bariya NH. A more relevant dissolution method for evaluation of floating drug delivery system. Dissolution Technol. 2004;11(4):22–5.

  58. 58.

    Bruschi ML. Mathematical models of drug release. In: Bruschi ML, editor. Strategies to modify the drug release from pharmaceutical systems; 2015. p. 63–86.

  59. 59.

    Shaikh HK, Kshirsagar R V, Patil SG. Mathematical models for drug release characterization: a review. World J Pharm Pharm Sci 2015;4(4):324–338.

  60. 60.

    Munday DL, Cox PJ. Compressed xanthan and karaya gum matrices: hydration, erosion and drug release mechanisms. Int J Pharm. 2000;203:179–92.

  61. 61.

    Higuchi T. Mechanism of sustained-action medication. J Pharm Sci. 1963;15:1145–9.

  62. 62.

    Llabot JM, Manzo RH, D a A. Drug release from carbomer:carbomer sodium salt matrices with potential use as mucoadhesive drug delivery system. Int J Pharm. 2004;276:59–66.

  63. 63.

    Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25–35.

  64. 64.

    Sayed E, Ruparelia K, Arshad MS, Chang M, Ahmad Z. Porous inorganic drug delivery systems—a review. AAPS PharmSciTech. 2017;18(5):1507–25.

  65. 65.

    Zhang C, Niu J, Chong Y, Huang Y, Chu Y, Xie S. Porous microspheres as promising vehicles for the topical delivery of poorly soluble asiaticoside accelerate wound healing and inhibit scar formation in vitro & in vivo. Eur J Pharm Biopharm. 2016;109:1–13.

  66. 66.

    Barrocas PMDC, Santos DFG, Ferreira DC, Coelho PMBDS, Oliveira RCS, Veiga FJDB. Pharmaceutical gastro-retentive systems | Sistemas farmacêuticos gastrorretentivos flutuantes. Rev Bras Ciencias Farm J Pharm Sci. 2007;43(3):325–34.

  67. 67.

    Eberle VA, Schoelkopf J, Gane PAC, Alles R, Huwyler J, Puchkov M. Floating gastroretentive drug delivery systems: comparison of experimental and simulated dissolution profiles and floatation behavior. Eur J Pharm Sci. 2014;58(1):34–43.

  68. 68.

    Dressman JB, Berardi RR, Dermentzoglou LC, Russell TL, Schmaltz SP, Barnett JL, Jarvenpaa KM Upper gastrointestinal (GI) pH in young, healthy men and women. Pharm Res 1990;7:756–61.

  69. 69.

    Kawashima Y, Niwa T, Takeuchi H, Hino T, Ito Y. Control of prolonged drug release and compression properties of ibuprofen microsponges with acrylic polymer, eudragit RS, by changing their intraparticle porosity. Chem Pharm Bull. 1992;40(1):196–201.

  70. 70.

    Philip A, Philip B. Colon targeted drug delivery systems: a review on primary and novel approaches. Oman Med J. 2010;25(2):70–8.

  71. 71.

    Sharma N, Harikumar SL. Polymers for colon targeted drug delivery: a review. Int J Drug Dev Res 2013;5(1):21–31.

  72. 72.

    Ramasamy T, Kandhasami UDS, Ruttala H, Shanmugam S. Formulation and evaluation of xanthan gum based aceclofenac tablets for colon targeted drug delivery. Brazilian J Pharm Sci. 2011;47(2):299–311.

  73. 73.

    Bruschi ML, Borghi-Pangoni FB, Junqueira MV, Ferreira SB de S. Nanostructured therapeutic systems with bioadhesive and thermoresponsive properties. In: Ficai D, Grumezescu AM, editors. Nanostructures for novel therapy synthesis, characterization and applications. Elsevier Inc.; 2017. p. 313–342.

  74. 74.

    Hoare TR, Kohane DS. Hydrogels in drug delivery. Polymer (Guildf). 2008;49:1993–2007.

Download references

Acknowledgments

The authors acknowledge the Brazilian agency CAPES (Coordination of Improvement of Higher Education Personnel).

Author information

Correspondence to Marcos Luciano Bruschi.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Junqueira, M.V., Bruschi, M.L. A Review About the Drug Delivery from Microsponges. AAPS PharmSciTech 19, 1501–1511 (2018). https://doi.org/10.1208/s12249-018-0976-5

Download citation

KEY WORDS

  • drug delivery
  • microsponges
  • release profile
  • permeation
  • microparticulate systems